- Home
- IMNM vs OCFC Comparison
IMNM vs OCFC Comparison
Compare IMNM & OCFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- OCFC
- Stock Information
- Founded
- IMNM 2006
- OCFC 1902
- Country
- IMNM United States
- OCFC United States
- Employees
- IMNM N/A
- OCFC N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- OCFC Major Banks
- Sector
- IMNM Health Care
- OCFC Finance
- Exchange
- IMNM Nasdaq
- OCFC Nasdaq
- Market Cap
- IMNM 748.3M
- OCFC 861.7M
- IPO Year
- IMNM 2020
- OCFC 1996
- Fundamental
- Price
- IMNM $9.06
- OCFC $16.70
- Analyst Decision
- IMNM Strong Buy
- OCFC Buy
- Analyst Count
- IMNM 5
- OCFC 4
- Target Price
- IMNM $26.40
- OCFC $21.25
- AVG Volume (30 Days)
- IMNM 973.9K
- OCFC 284.8K
- Earning Date
- IMNM 05-12-2025
- OCFC 07-17-2025
- Dividend Yield
- IMNM N/A
- OCFC 4.79%
- EPS Growth
- IMNM N/A
- OCFC N/A
- EPS
- IMNM N/A
- OCFC 1.53
- Revenue
- IMNM $10,938,000.00
- OCFC $369,879,000.00
- Revenue This Year
- IMNM N/A
- OCFC N/A
- Revenue Next Year
- IMNM $542.22
- OCFC $12.29
- P/E Ratio
- IMNM N/A
- OCFC $10.99
- Revenue Growth
- IMNM N/A
- OCFC N/A
- 52 Week Low
- IMNM $5.15
- OCFC $14.03
- 52 Week High
- IMNM $16.81
- OCFC $21.87
- Technical
- Relative Strength Index (RSI)
- IMNM 61.94
- OCFC 47.33
- Support Level
- IMNM $8.50
- OCFC $16.58
- Resistance Level
- IMNM $9.04
- OCFC $17.70
- Average True Range (ATR)
- IMNM 0.54
- OCFC 0.44
- MACD
- IMNM 0.09
- OCFC -0.08
- Stochastic Oscillator
- IMNM 90.18
- OCFC 17.83
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About OCFC OceanFirst Financial Corp.
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.